Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.57 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5310166 | 1.00 | LMNA (0.64) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| SCHEMBL16672854 | 0.95 | TDP1 (0.58) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| SCHEMBL9180923 | 0.93 | HTT (0.56) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| SCHEMBL6989966 | 0.93 | HTT (0.56) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| Acrylic Acid SCHEMBL28013212 | 0.91 | LMNA (0.54) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| Phenethyl Propionate SCHEMBL114088 | 0.89 | TDP1 (0.63) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| SCHEMBL8817029 | 0.86 | TDP1 (0.66) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| Phenethyl Propionate SCHEMBL28805171 | 0.86 | TDP1 (0.59) | LMNATDP1SMN1; SMN2ALDH1A1CTDSP1 | |
| Phenethyl Propionate SCHEMBL4653082 | 0.86 | TDP1 (0.59) | LMNATDP1SMN1; SMN2ALDH1A1KDM4E | |
| Phenethyl Propionate SCHEMBL27857110 | 0.86 | TDP1 (0.59) | LMNATDP1SMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816291-A | Agent for promoting formation of horny layer | 株式会社资生堂 | 2025-04-11 | — | — | CN | claimed |
| WO-2024062675-A1 | STRATUM CORNEUM FORMATION PROMOTER | 株式会社 資生堂 | 2024-03-28 | — | — | WO | claimed |
| CN-110300791-A | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter, and image display device | 东友精细化工有限公司 | 2019-10-01 | — | — | CN | claimed |
| US-9050295-B2 | Composition for treatment of tuberculosis | ETH ZURICH (CH) | 2015-06-09 | — | — | US | claimed |
| EP-2234643-B1 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS | ETH ZUERICH (CH) | 2013-01-09 | — | — | EP | claimed |
| US-20110053880-A1 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS | ETH ZURICH (CH) | 2011-03-03 | — | — | US | claimed |
| EP-2234643-A2 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS | ETH Zurich (CH) | 2010-10-06 | — | — | EP | claimed |
| EP-1967080-B1 | Non-aldehyde cinnamon flavor and delivery systems therefor | CADBURY ADAMS USA LLC (US) | 2010-06-02 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2009080432-A2 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS | ETH ZURICH (CH) | 2009-07-02 | — | — | WO | claimed |
| EP-1967080-A1 | Non-aldehyde cinnamon flavor and delivery systems therefor | Cadbury Adams USA LLC (US) | 2008-09-10 | — | — | EP | claimed |
| US-20080213440-A1 | Non-Aldehyde Cinnamon Flavor and Delivery Systems Therefor | CADBURY ADAMS USA LLC (US) | 2008-09-04 | — | — | US | claimed |
| CN-119816291-A | Agent for promoting formation of horny layer | 株式会社资生堂 | 2025-04-11 | — | — | CN | disclosed |
| US-20240277012-A1 | DUPLICATE BEVERAGE | WANG JIE (US) | 2024-08-22 | — | — | US | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024062675-A1 | STRATUM CORNEUM FORMATION PROMOTER | 株式会社 資生堂 | 2024-03-28 | — | — | WO | disclosed |
| CN-1404474-A | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibitors | ASTRAZENECA AB (SE) | 2003-03-19 | — | — | CN | disclosed |
| EP-0044541-B1 | AMINOCARBOXYLIC ACIDS, AMINO ALCOHOLS, OR THE DERIVATIVES THEREOF, PROCESSES FOR PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION, CONTAINING AT LEAST ONE OF THESE COMPOUNDS | TEIJIN LIMITED (JP) | 1983-09-21 | — | — | EP | disclosed |
| US-4402975-A | ANTIULCER AGENTS | TEIJIN LIMITED (JP) | 1983-09-06 | — | — | US | disclosed |
| EP-0044541-A1 | Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical composition, containing at least one of these compounds | TEIJIN LIMITED (JP) | 1982-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | LMNA 4834/4885TDP1 2650/4885SMN1; SMN2 1778/4885 |
| US-20110053880-A1 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS | NCOR1, NCOR2, ESRRA | LMNA 3188/4885TDP1 3153/4885SMN1; SMN2 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.